Find Your Broker
Share Name Share Symbol Market Type Share ISIN Share Description
UDG Healthcare LSE:UDG London Ordinary Share IE0033024807 ORD EUR0.05
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +2.00p +0.35% 581.00p 582.00p 583.00p 588.50p 573.00p 573.00p 934,245 16:35:05
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Food & Drug Retailers 1,170.9 93.9 1.4 436.1 1,442.78

UDG Healthcare Public Limited Co. Notice of Q1 2019 Trading Update

14/01/2019 10:29am

UK Regulatory (RNS & others)

UDG Healthcare (LSE:UDG)
Historical Stock Chart

1 Month : From Dec 2018 to Jan 2019

Click Here for more UDG Healthcare Charts.


RNS Number : 0182N

UDG Healthcare Public Limited Co.

14 January 2019

14 January 2019

UDG Healthcare plc

Notice of Q1 2019 Trading Update

UDG Healthcare plc ("UDG Healthcare" or "Group"), a leading international healthcare services provider, will issue a trading update for the first quarter to 31 December 2018 at 7.00 a.m. (GMT) on Tuesday, 29 January 2019.

The Company will also host a conference call for investors and analysts at 9.00am (GMT) on Tuesday, 29 January 2019 to discuss the statement. The dial-in details are as follows:

  Standard International 
                  Access   +44 (0) 20 3003 2666 
            UK Toll Free   0808 109 0700 
                 Ireland   +353 (0) 1 436 0959 
                Password   UDG Healthcare 

A playback facility will be available for seven days on +44 (0) 20 8196 1480. The access code for the replay will be 8581787#.

For further information, please contact:

Keith Byrne

Head of Investor Relations, Strategy & Corporate Communications

UDG Healthcare plc

Tel: +353-1-468-9000

Lisa Kavanagh / Jack Hickey


Tel: +44-207-250-1446


About UDG Healthcare plc:

UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering advisory, communication, commercial, clinical and packaging services to the healthcare industry, employing over 8,500 people with operations in 26 countries and delivering services in over 50 countries.

UDG Healthcare plc operates across two divisions: Ashfield and Sharp.

Ashfield is a global leader in advisory, communication, commercial and clinical services for the pharmaceutical and healthcare industries. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies.

Sharp is a global leader in contract commercial packaging and clinical trial packaging services for the pharmaceutical and healthcare industries, operating from state-of the-art facilities in the US and Europe.

The company is listed on the London Stock Exchange and is a constituent of the FTSE 250. For more information, please go to:

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit



(END) Dow Jones Newswires

January 14, 2019 05:29 ET (10:29 GMT)

1 Year UDG Healthcare Chart

1 Year UDG Healthcare Chart

1 Month UDG Healthcare Chart

1 Month UDG Healthcare Chart
Your Recent History
UDG Health..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20190124 01:56:49